NCT06963346 2026-03-09
Study Investigating Intravesical HDAC Inhibition to Improve Response to Immuno-Oncology Agents
H. Lee Moffitt Cancer Center and Research Institute
Phase 1 Suspended
Clinical Trials
35 trialsNCT05597878 2026-03-06
Opioid-Free Pain Control Regimen Following Robotic Radical Prostatectomy
Wake Forest University Health Sciences
Phase 2/3 Suspended
NCT06860386 2026-03-06
Study of Adaptive Immunotherapy With VEGFR-TKI in Patients With Advanced RCC
H. Lee Moffitt Cancer Center and Research Institute
Phase 2 Suspended
NCT06085729 2026-02-27
Phase I/II Study of PEGylated Arginine Deiminase (ADI-PEG20) With Carboplatin and Cabazitaxel in Men With Aggressive Variant Prostate Cancers (AVPC)
M.D. Anderson Cancer Center
Phase 1/2 Suspended
NCT05000294 2026-02-18
Atezolizumab Plus Tivozanib in Immunologically Cold Tumor Types
University of Florida
Phase 1/2 Suspended
NCT05928806 2026-02-11
ARCITECT
Hoosier Cancer Research Network
Phase 2 Suspended
NCT06733350 2026-02-09
Testosterone Replacement Therapy for the Treatment of Low Testosterone in Hypogonadal Men With Localized Prostate Cancer on Active Surveillance
Roswell Park Cancer Institute
Phase 4 Suspended
NCT05148156 2026-01-27
Urolift Pre-SBRT for Reduced Urinary Toxicity in Patients With BPH and Prostate Cancer.
Northwell Health
Phase NA Suspended
NCT04981834 2026-01-16
Robot-Assisted Radical Prostatectomy With or Without Vesicopexy in Patients With Prostate Cancer
University of Southern California
Phase NA Suspended
NCT06049576 2025-12-17
Nivolumab and Ipilimumab With and Without Camu Camu for the Treatment of Patients With Metastatic Renal Cell Carcinoma
City of Hope Medical Center
Phase 1 Suspended
NCT03575611 2025-10-28
Stereotactic Body Radiation Therapy in Treating Patients With Oligometastatic Renal Cell Carcinoma
M.D. Anderson Cancer Center
Phase 2 Suspended
NCT05362032 2025-10-24
Feasibility of OmnEcoil System for Integrated Endorectal MRI and Transrectal MRI-Targeted Biopsy of the Prostate
OHSU Knight Cancer Institute
Phase NA Suspended
NCT05445609 2025-09-19
Vidutolimod (CMP-001) in Combination With Nivolumab for the Treatment of Metastatic Castration Resistant Prostate Cancer
Emory University
Phase 2 Suspended
NCT05820633 2025-09-12
PCS-XI
CHU de Quebec-Universite Laval
Phase NA Suspended
NCT04886986 2025-06-27
Phase I/II 225Ac-J591 Plus 177Lu-PSMA-I&T for Progressive Metastatic Castration Resistant Prostate Cancer
Weill Medical College of Cornell University
Phase 1/2 Suspended
NCT05958199 2025-06-27
A Study of NPX267 for Subjects With Solid Tumors Known to Express HHLA2/B7-H7
NextPoint Therapeutics, Inc.
Phase 1 Suspended
NCT06282185 2025-05-04
Superman
Canisius-Wilhelmina Hospital
Phase NA Suspended
NCT06059014 2025-02-24
PRadR
Centre Leon Berard
Phase 1/2 Suspended
NCT04684628 2024-05-02
68Ga-PSMA PET/CT in Prostate Cancer
University of Saskatchewan
Phase 3 Suspended
NCT04714983 2024-04-09
DNX-2440 for Resectable Colorectal Liver Metastasis
DNAtrix, Inc.
Phase 1 Suspended
NCT06355843 2024-04-09
Clinical Applications of Integrated PET/MR and PET/CT in the Diagnosis and Treatment of Prostate Cancer.
The First Affiliated Hospital of Anhui Medical University
Phase NA Suspended
NCT05361915 2024-03-18
Study to Assess Abivertinib in Combination With Abiraterone in Metastatic Castration Resistant Prostate Cancer
Sorrento Therapeutics, Inc.
Phase 2 Suspended
NCT04053062 2024-01-05
LIGHT-PSMA-CART in Treating Patients With Castrate-Resistant Prostate Cancer
Bioray Laboratories
Phase 1 Suspended
NCT06185478 2023-12-29
Prostate Diffusion Imaging With Distortion Correction
Norfolk and Norwich University Hospitals NHS Foundation Trust
Phase NA Suspended
NCT05425862 2023-12-11
REPAIR
Peter MacCallum Cancer Centre, Australia
Phase 1 Suspended
NCT02091661 2020-03-25
Radical Retropubic Prostatectomy Versus Conventional External Beam Radiotherapy for Clinically Localized Prostate Cancer
University of Rome Tor Vergata
Phase 3 Suspended
NCT03734575 2019-07-11
ClariCore System Used in Transperineal Prostate Biopsy
Precision Biopsy, Inc.
Phase NA Suspended
NCT00664196 2016-06-17
Trial of Anti-PSMA Designer T Cells in Advanced Prostate Cancer After Non-Myeloablative Conditioning
Roger Williams Medical Center
Phase 1 Suspended
NCT01337518 2012-12-18
A Phase 1a/1b Study to Evaluate the Safety of EZN-4176, in Adult Patients With Castration-Resistant Prostate Cancer
Enzon Pharmaceuticals, Inc.
Phase 1 Suspended
NCT01604863 2012-11-01
A Study of HGS1036 in Combination With Chemotherapy in Subjects With Advanced Solid Malignancies
GlaxoSmithKline
Phase 1 Suspended
NCT00065572 2011-01-26
Exploratory Study to Assess the Biological Activity of ZD6126 in Subjects With Newly Diagnosed Metastatic Renal Cell Carcinoma (Stage IV)
AstraZeneca
Phase 2 Suspended
NCT00909558 2010-02-24
Safety and Effectiveness Study of Autologous Natural Killer and Natural Killer T Cells on Cancer
Envita Medical Center, Inc.
Phase 1 Suspended
NCT00103623 2006-09-19
The Plenaxis® Experience Study
PRAECIS Pharmaceuticals Inc.
Phase 4 Suspended
NCT00127088 2006-09-11
Study of Peri-Operative Docetaxel Plus Laparoscopic Radical Prostatectomy in Prostate Cancer Patients
Gustave Roussy, Cancer Campus, Grand Paris
Phase 2 Suspended
NCT00033956 2005-06-24
Evaluation of M40403 for the Prevention of Dose Limiting Toxicities of High Dose IL-2
MetaPhore Pharmaceuticals
Phase 1/2 Suspended